18F-FTC-146 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
206脆弱X症候群1

206. 脆弱X症候群


臨床試験数 : 108 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04314856
(ClinicalTrials.gov)
January 12, 202111/3/2020Novel Clinical Target in Fragile X SyndromeSigma-1 Receptors: A Novel Clinical Target in Fragile X SyndromeFragile X Syndrome (FXS)Drug: 18F-FTC-146Guido A. Davidzon, MD, SMNULLWithdrawn18 Years65 YearsAll0Phase 1United States